PortfoliosLab logo
ALHC vs. CLOV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALHC and CLOV is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

ALHC vs. CLOV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alignment Healthcare Holdings, LLC (ALHC) and Clover Health Investments, Corp. (CLOV). The values are adjusted to include any dividend payments, if applicable.

-60.00%-40.00%-20.00%0.00%20.00%December2025FebruaryMarchAprilMay
-12.65%
-53.15%
ALHC
CLOV

Key characteristics

Sharpe Ratio

ALHC:

1.94

CLOV:

3.77

Sortino Ratio

ALHC:

2.68

CLOV:

4.38

Omega Ratio

ALHC:

1.34

CLOV:

1.53

Calmar Ratio

ALHC:

1.60

CLOV:

3.89

Martin Ratio

ALHC:

11.58

CLOV:

21.78

Ulcer Index

ALHC:

10.37%

CLOV:

17.19%

Daily Std Dev

ALHC:

61.86%

CLOV:

82.35%

Max Drawdown

ALHC:

-83.61%

CLOV:

-97.16%

Current Drawdown

ALHC:

-44.55%

CLOV:

-83.95%

Fundamentals

Market Cap

ALHC:

$3.07B

CLOV:

$1.69B

EPS

ALHC:

-$0.47

CLOV:

-$0.09

PS Ratio

ALHC:

1.02

CLOV:

1.23

PB Ratio

ALHC:

28.32

CLOV:

4.95

Total Revenue (TTM)

ALHC:

$3.00B

CLOV:

$1.02B

Gross Profit (TTM)

ALHC:

$347.34M

CLOV:

$283.04M

EBITDA (TTM)

ALHC:

-$40.24M

CLOV:

-$22.08M

Returns By Period

In the year-to-date period, ALHC achieves a 34.40% return, which is significantly higher than CLOV's 11.43% return.


ALHC

YTD

34.40%

1M

-18.45%

6M

10.61%

1Y

118.81%

5Y*

N/A

10Y*

N/A

CLOV

YTD

11.43%

1M

-3.31%

6M

2.93%

1Y

306.58%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALHC vs. CLOV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALHC
The Risk-Adjusted Performance Rank of ALHC is 9393
Overall Rank
The Sharpe Ratio Rank of ALHC is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of ALHC is 9393
Sortino Ratio Rank
The Omega Ratio Rank of ALHC is 9090
Omega Ratio Rank
The Calmar Ratio Rank of ALHC is 9191
Calmar Ratio Rank
The Martin Ratio Rank of ALHC is 9696
Martin Ratio Rank

CLOV
The Risk-Adjusted Performance Rank of CLOV is 9898
Overall Rank
The Sharpe Ratio Rank of CLOV is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of CLOV is 9898
Sortino Ratio Rank
The Omega Ratio Rank of CLOV is 9797
Omega Ratio Rank
The Calmar Ratio Rank of CLOV is 9898
Calmar Ratio Rank
The Martin Ratio Rank of CLOV is 9999
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ALHC vs. CLOV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Alignment Healthcare Holdings, LLC (ALHC) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current ALHC Sharpe Ratio is 1.94, which is lower than the CLOV Sharpe Ratio of 3.77. The chart below compares the historical Sharpe Ratios of ALHC and CLOV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00December2025FebruaryMarchAprilMay
1.94
3.77
ALHC
CLOV

Dividends

ALHC vs. CLOV - Dividend Comparison

Neither ALHC nor CLOV has paid dividends to shareholders.


TTM2024202320222021
ALHC
Alignment Healthcare Holdings, LLC
0.00%0.00%0.00%0.00%0.00%
CLOV
Clover Health Investments, Corp.
0.00%0.00%0.00%0.00%2.69%

Drawdowns

ALHC vs. CLOV - Drawdown Comparison

The maximum ALHC drawdown since its inception was -83.61%, smaller than the maximum CLOV drawdown of -97.16%. Use the drawdown chart below to compare losses from any high point for ALHC and CLOV. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%December2025FebruaryMarchAprilMay
-44.55%
-83.95%
ALHC
CLOV

Volatility

ALHC vs. CLOV - Volatility Comparison

The current volatility for Alignment Healthcare Holdings, LLC (ALHC) is 15.32%, while Clover Health Investments, Corp. (CLOV) has a volatility of 17.13%. This indicates that ALHC experiences smaller price fluctuations and is considered to be less risky than CLOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


8.00%10.00%12.00%14.00%16.00%18.00%20.00%22.00%December2025FebruaryMarchAprilMay
15.32%
17.13%
ALHC
CLOV

Financials

ALHC vs. CLOV - Financials Comparison

This section allows you to compare key financial metrics between Alignment Healthcare Holdings, LLC and Clover Health Investments, Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-500.00M0.00500.00M1.00B20212022202320242025
926.93M
336.96M
(ALHC) Total Revenue
(CLOV) Total Revenue
Values in USD except per share items

ALHC vs. CLOV - Profitability Comparison

The chart below illustrates the profitability comparison between Alignment Healthcare Holdings, LLC and Clover Health Investments, Corp. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-10.0%0.0%10.0%20.0%30.0%20212022202320242025
11.4%
27.9%
(ALHC) Gross Margin
(CLOV) Gross Margin
ALHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Alignment Healthcare Holdings, LLC reported a gross profit of 106.03M and revenue of 926.93M. Therefore, the gross margin over that period was 11.4%.

CLOV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported a gross profit of 93.92M and revenue of 336.96M. Therefore, the gross margin over that period was 27.9%.

ALHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Alignment Healthcare Holdings, LLC reported an operating income of -5.39M and revenue of 926.93M, resulting in an operating margin of -0.6%.

CLOV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported an operating income of -21.45M and revenue of 336.96M, resulting in an operating margin of -6.4%.

ALHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Alignment Healthcare Holdings, LLC reported a net income of -9.11M and revenue of 926.93M, resulting in a net margin of -1.0%.

CLOV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported a net income of -22.09M and revenue of 336.96M, resulting in a net margin of -6.6%.